Published finding — does the expert body still believe it?
The REVASCAT trial's stated primary conclusion — Thrombectomy up to 8h after stroke onset is superior to medical therapy in selected patients. — replicates in independent cohorts.
TL;DR · AI-generated
Among patients with anterior circulation stroke who could be treated within 8 hours after symptom onset, stent retriever thrombectomy reduced the severity of post-stroke disability and increased the rate of functional independence.
Your position — does this noeme still stand given current evidence?
0% (impossible)
50%
100% (certain)
Proper-scoring-rule preview
Your position is kept on this device until you sign in.
Evidence stream
2 events · 1 snapshot
posterior drift
71% → 71% (0pp · 1 point)
Registry data
Apr 18, 2026
Peer-reviewed paper
Apr 18, 2026
Expert reactions · 0
Sign in to post a take, cite a related claim, or flag a methodological concern.
No reactions yet. Be the first expert to post a take, cite a related claim, or flag a methodological concern.
Source publication
Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke
Tudor G. Jovin et al. · New England Journal of Medicine · 2015
· openalex W2143237216 · s2 64ea7e29
Semantically related
Nearest claims in the expert-corpus vector space. Ordered by cosine distance — lower is closer.
0.0736
The DEFUSE-3 trial's stated primary conclusion — Imaging-selected patients benefit from thrombectomy 6–16h after last-known-well. — replicates in independent cohorts.
0.0779
The MR CLEAN trial's stated primary conclusion — Endovascular thrombectomy within 6h improves functional outcome in proximal anterior circulation stroke. — replicates in independent cohorts.
0.0788
The DAWN trial's stated primary conclusion — Mechanical thrombectomy benefits selected large-vessel-occlusion stroke patients in the 6–24h window. — replicates in independent cohorts.
0.0923
The EXTEND-IA trial's stated primary conclusion — CT-perfusion-selected thrombectomy produces early neurological improvement vs. tPA alone. — replicates in independent cohorts.
0.1038
The ESCAPE trial's stated primary conclusion — Rapid endovascular treatment improves functional outcomes in proximal anterior-circulation stroke. — replicates in independent cohorts.
0.1149
The SWIFT PRIME trial's stated primary conclusion — Stent-retriever thrombectomy plus tPA is superior to tPA alone for proximal anterior-circulation stroke. — replicates in independent cohorts.